Arhaus Balance Sheet Health

Financial Health criteria checks 6/6

Arhaus has a total shareholder equity of $340.2M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $1.1B and $773.9M respectively. Arhaus's EBIT is $163.9M making its interest coverage ratio -48.9. It has cash and short-term investments of $223.1M.

Key information

0%

Debt to equity ratio

US$0

Debt

Interest coverage ratio-48.9x
CashUS$223.10m
EquityUS$340.24m
Total liabilitiesUS$773.86m
Total assetsUS$1.11b

Recent financial health updates

No updates

Recent updates

Arhaus (NASDAQ:ARHS) Is Reinvesting To Multiply In Value

Apr 19
Arhaus (NASDAQ:ARHS) Is Reinvesting To Multiply In Value

Optimistic Investors Push Arhaus, Inc. (NASDAQ:ARHS) Shares Up 26% But Growth Is Lacking

Mar 14
Optimistic Investors Push Arhaus, Inc. (NASDAQ:ARHS) Shares Up 26% But Growth Is Lacking

Calculating The Intrinsic Value Of Arhaus, Inc. (NASDAQ:ARHS)

Mar 05
Calculating The Intrinsic Value Of Arhaus, Inc. (NASDAQ:ARHS)

Arhaus: Doing Better Than Peers, But The Stock Is Pricey

Feb 11

Capital Investment Trends At Arhaus (NASDAQ:ARHS) Look Strong

Jan 04
Capital Investment Trends At Arhaus (NASDAQ:ARHS) Look Strong

Calculating The Intrinsic Value Of Arhaus, Inc. (NASDAQ:ARHS)

Dec 05
Calculating The Intrinsic Value Of Arhaus, Inc. (NASDAQ:ARHS)

Impressive Earnings May Not Tell The Whole Story For Arhaus (NASDAQ:ARHS)

Nov 09
Impressive Earnings May Not Tell The Whole Story For Arhaus (NASDAQ:ARHS)

Arhaus (NASDAQ:ARHS) Is Investing Its Capital With Increasing Efficiency

Sep 27
Arhaus (NASDAQ:ARHS) Is Investing Its Capital With Increasing Efficiency

Does Arhaus (NASDAQ:ARHS) Deserve A Spot On Your Watchlist?

Aug 20
Does Arhaus (NASDAQ:ARHS) Deserve A Spot On Your Watchlist?

Calculating The Fair Value Of Arhaus, Inc. (NASDAQ:ARHS)

Aug 02
Calculating The Fair Value Of Arhaus, Inc. (NASDAQ:ARHS)

Arhaus (NASDAQ:ARHS) Is Very Good At Capital Allocation

Jun 28
Arhaus (NASDAQ:ARHS) Is Very Good At Capital Allocation

With EPS Growth And More, Arhaus (NASDAQ:ARHS) Makes An Interesting Case

May 09
With EPS Growth And More, Arhaus (NASDAQ:ARHS) Makes An Interesting Case

Calculating The Fair Value Of Arhaus, Inc. (NASDAQ:ARHS)

Apr 08
Calculating The Fair Value Of Arhaus, Inc. (NASDAQ:ARHS)

The Market Doesn't Like What It Sees From Arhaus, Inc.'s (NASDAQ:ARHS) Earnings Yet As Shares Tumble 33%

Mar 11
The Market Doesn't Like What It Sees From Arhaus, Inc.'s (NASDAQ:ARHS) Earnings Yet As Shares Tumble 33%

Arhaus (NASDAQ:ARHS) Will Be Hoping To Turn Its Returns On Capital Around

Feb 01
Arhaus (NASDAQ:ARHS) Will Be Hoping To Turn Its Returns On Capital Around

With EPS Growth And More, Arhaus (NASDAQ:ARHS) Makes An Interesting Case

Jan 11
With EPS Growth And More, Arhaus (NASDAQ:ARHS) Makes An Interesting Case

Earnings Beat: Arhaus, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Nov 13
Earnings Beat: Arhaus, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Arhaus: Strong Growth Despite Macro Headwinds

Sep 25

Arhaus Is A Good Company But It Is Too Risky

Sep 11

Arhaus names Tim Kuckelman as COO

Aug 22

Arhaus GAAP EPS of $0.27 beats by $0.18, revenue of $306.27M beats by $54.66M

Aug 11

Arhaus: There's Better Out There

Mar 15

Financial Position Analysis

Short Term Liabilities: ARHS's short term assets ($528.3M) exceed its short term liabilities ($351.3M).

Long Term Liabilities: ARHS's short term assets ($528.3M) exceed its long term liabilities ($422.6M).


Debt to Equity History and Analysis

Debt Level: ARHS is debt free.

Reducing Debt: ARHS had no debt 5 years ago.

Debt Coverage: ARHS has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: ARHS has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.